Physician profile
James Eberhardt
NPI 1982727756
$60,700.91
in general payments reported to CMS, 2019-2025
12 companies · $1,791 in 2025
The $1,791 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $2,545 · 2021: $9,727 · 2022: $23K · 2023: $6,813 · 2024: $375 · 2025: $1,791.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,890 · Travel and Lodging: $2,308 · Food and Beverage: $1,780.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,890.00 |
| Travel and Lodging | $2,308.29 |
| Food and Beverage | $1,780.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exactech, INC. | $39,555.37 | 2019-2023 | |
| Zimmer Biomet Holdings, INC. | $9,665.26 | 2019-2020 | |
| Stryker Corporation | $9,441.29 | 2019-2025 | Mako, Triathlon |
| Medacta USA, INC. | $1,052.90 | 2019 | |
| Smith+Nephew, INC. | $617.53 | 2019-2024 | Bone Anchors With Arthroscopic Delivery System, Firstpass, Healicoil |
| Pacira Pharmaceuticals Incorporated | $134.06 | 2019-2023 | Iovera |
| Depuy Synthes Sales INC. | $61.09 | 2020-2022 | |
| Bioventus LLC | $49.36 | 2021-2022 | |
| Heron Therapeutics, INC. | $48.26 | 2021-2024 | Zynrelef |
| Ethicon US, LLC | $38.91 | 2022 | |
| Orthofix Medical, INC. | $23.12 | 2019-2020 | |
| Medtronic USA, INC. | $13.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Eberhardt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.